Sponsor Pipeline

Stoke Therapeutics, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT06872125
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in…		 Trial sites expanded: 58 -> 61 locations
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06872125 A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in… Dravet Syndrome Recruiting
Phase 2
NCT04740476 An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome Dravet Syndrome Active, Not Recruiting
Get alerts when Stoke Therapeutics, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free